Drug Information

Drug General Information
Drug ID
D0Q9IK
Former ID
DNCL002143
Drug Name
CEP-9722
Indication Cerebrovascular ischaemia; Non-small cell lung cancer [ICD9: 434.91; ICD10:I61-I63, C33-C34] Phase 1/2 [523387]
Company
Cephalon
Structure
Download
2D MOL

3D MOL
Target and Pathway
Target(s) Poly ADP ribose polymerase (PARP) Target Info Modulator [1572591]
References
Ref 523387ClinicalTrials.gov (NCT01311713) Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Patients With Solid Tumors. U.S. National Institutes of Health.
Ref 1572591Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.